Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
616
610
DOI:
10.1016/j.ymthe.2025.02.024
Publication Date:
2025-02-15T23:57:26Z
AUTHORS (21)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (78)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....